124 related articles for article (PubMed ID: 10573477)
1. Single high-dose immunoglobulin therapy for childhood Guillain-Barré syndrome.
Zafeiriou DI; Kontopoulos EE; Katzos GS; Gombakis NP; Kanakoudi FG
J Child Neurol; 1999 Jul; 14(7):480-1. PubMed ID: 10573477
[No Abstract] [Full Text] [Related]
2. Intravenous immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial.
DiMario FJ
Pediatrics; 2005 Jul; 116(1):226-8. PubMed ID: 15995056
[No Abstract] [Full Text] [Related]
3. [Guillain-Barré syndrome with preserved reflexes].
Zouiri G; Abilkassem R; Zerhouni A; Dini N; Agadr A
Arch Pediatr; 2016 May; 23(5):501-3. PubMed ID: 27021810
[TBL] [Abstract][Full Text] [Related]
4. Landry Guillian-Barre Strohl syndrome in pregnancy: use of high-dose intravenous immunoglobulin.
Seoud M; Naboulsi M; Khalil A; Sarouphim P; Azar G; Khalifeh R
Acta Obstet Gynecol Scand; 1999 Nov; 78(10):912-3. PubMed ID: 10577623
[No Abstract] [Full Text] [Related]
5. Ten-year prospective study (clinical spectrum) of childhood Guillain-Barré syndrome in the Arabian peninsula: comparison of outcome in patients in the pre- and post-intravenous immunoglobulin eras.
Koul R; Chacko A; Ahmed R; Varghese T; Javed H; Al-Lamki Z
J Child Neurol; 2003 Nov; 18(11):767-71. PubMed ID: 14696904
[TBL] [Abstract][Full Text] [Related]
6. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.
Walgaard C; Jacobs BC; Lingsma HF; Steyerberg EW; van den Berg B; Doets AY; Leonhard SE; Verboon C; Huizinga R; Drenthen J; Arends S; Budde IK; Kleyweg RP; Kuitwaard K; van der Meulen MFG; Samijn JPA; Vermeij FH; Kuks JBM; van Dijk GW; Wirtz PW; Eftimov F; van der Kooi AJ; Garssen MPJ; Gijsbers CJ; de Rijk MC; Visser LH; Blom RJ; Linssen WHJP; van der Kooi EL; Verschuuren JJGM; van Koningsveld R; Dieks RJG; Gilhuis HJ; Jellema K; van der Ree TC; Bienfait HME; Faber CG; Lovenich H; van Engelen BGM; Groen RJ; Merkies ISJ; van Oosten BW; van der Pol WL; van der Meulen WDM; Badrising UA; Stevens M; Breukelman AJ; Zwetsloot CP; van der Graaff MM; Wohlgemuth M; Hughes RAC; Cornblath DR; van Doorn PA;
Lancet Neurol; 2021 Apr; 20(4):275-283. PubMed ID: 33743237
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome.
Korinthenberg R
Eur J Paediatr Neurol; 1998; 2(1):57-9. PubMed ID: 10726847
[No Abstract] [Full Text] [Related]
8. The successful use of i.v. gammaglobulin for Guillain-Barré syndrome following gold therapy in an RA patient.
Tektonidou MG; Skopouli FN
Clin Exp Rheumatol; 2003; 21(3):404-5. PubMed ID: 12846068
[No Abstract] [Full Text] [Related]
9. Effect of methylprednisolone in patients with Guillain-Barré syndrome.
Susuki K; Yuki N
Lancet; 2004 Apr; 363(9416):1236-7; author reply 1237-8. PubMed ID: 15081664
[No Abstract] [Full Text] [Related]
10. Effect of methylprednisolone in patients with Guillain-Barré syndrome.
Rossi G; Locatelli F
Lancet; 2004 Apr; 363(9416):1237; author reply 1237-8. PubMed ID: 15081665
[No Abstract] [Full Text] [Related]
11. High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
Nobile-Orazio E; Bersano A
Neurol Sci; 2002 Apr; 23 Suppl 1():S25-32. PubMed ID: 12032584
[No Abstract] [Full Text] [Related]
12. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
Zeidman LA; Fahey CD; Grinblatt DL; Harsanyi K
Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous Guillain-Barré syndrome and acute disseminated encephalomyelitis in the pediatric population.
Bernard G; Riou E; Rosenblatt B; Dilenge ME; Poulin C
J Child Neurol; 2008 Jul; 23(7):752-7. PubMed ID: 18354151
[TBL] [Abstract][Full Text] [Related]
14. [Intravenous immunoglobulin therapy in neuroimmunological disorders].
Komoly S
Ideggyogy Sz; 2014 Jul; 67(7-8):281-2. PubMed ID: 25509371
[No Abstract] [Full Text] [Related]
15. Human immunoglobulin and the Guillain-Barre syndrome: new indication. An alternative to plasmapheresis.
Prescrire Int; 2000 Oct; 9(49):142-3. PubMed ID: 11603414
[TBL] [Abstract][Full Text] [Related]
16. [Case report; A case of anti-GD1b antibody positive pure motor form Guillain-Barré syndrome with good response to combined IVIg and steroid therapy].
Fujimoto T; Fukuda Y; Eguchi K; Kusunoki S
Nihon Naika Gakkai Zasshi; 2011 Jun; 100(6):1651-3. PubMed ID: 21770292
[No Abstract] [Full Text] [Related]
17. [Present status of high-dose intravenous immunoglobulin therapy and the future prospects ].
Kawasugi K
Nihon Rinsho Meneki Gakkai Kaishi; 2003 Jun; 26(3):87-95. PubMed ID: 12868126
[No Abstract] [Full Text] [Related]
18. Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study.
Garssen MP; van Koningsveld R; van Doorn PA; Merkies IS; Scheltens-de Boer M; van Leusden JA; van Schaik IN; Linssen WH; Visscher F; Boon AM; Faber CG; Meulstee J; Prick MJ; van den Berg LH; Franssen H; Hiel JA; van den Bergh PY; Sindic CJ
J Neurol Neurosurg Psychiatry; 2007 Sep; 78(9):1012-3. PubMed ID: 17702789
[No Abstract] [Full Text] [Related]
19. Generalized tetanus could be complicated with Guillain-Barré syndrome.
Lee JH; Hwang YS; Cho JH
Int J Infect Dis; 2016 Jul; 48():20-1. PubMed ID: 27109107
[TBL] [Abstract][Full Text] [Related]
20. Single dose immunoglobulin therapy for childhood Guillain-Barré syndrome.
Zafeiriou DI; Kontopoulos EE; Katzos GS; Gombakis NP; Kanakoudi FG
Brain Dev; 1997 Jul; 19(5):323-5. PubMed ID: 9253484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
